Percheron Therapeutics Ltd

(ASX) PER

Current Price$0.01

Market Cap$7.61M

Since IPO (2001)-100%

5 Year-98%

1 Year-44%

1 Month+0%

Percheron Therapeutics Ltd Financials at a Glance

Market Cap

$7.61M

Revenue (TTM)

$0.00

Net Income (TTM)

$25.20M

EPS (TTM)

$-0.01

P/E Ratio

-0.59

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.01

Volume

7,590,918

Open

$0.00

Price

$0.01

Volume

7,590,918

Open

$0.00

Previous Close

$0.01

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.01

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.01

Volume

7,590,918

Open

$0.00

Previous Close

$0.01

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.01

PER News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Percheron Therapeutics Ltd

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

James Stuart Garner, PhD, MBA

Website

www.PercheronTx.com

Headquarters

Melbourne, VIC 3000, AU

PER Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-85%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-1.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.61M

Shares Outstanding

1.52B

Volume

7.59M

Avg. Volume

1.48M

Financials (TTM)

Gross Profit

$67.98K

Operating Income

$16.71M

EBITDA

$16.27M

Operating Cash Flow

$15.64M

Capital Expenditure

$7.24K

Free Cash Flow

$15.65M

Cash & ST Invst.

$10.17M

Total Debt

$25.86K

Percheron Therapeutics Ltd Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$19.12K

+59.7%

Gross Margin

0.00%

N/A

Market Cap

$7.61M

N/A

Market Cap/Employee

$951.51K

N/A

Employees

N/A

Net Income

$3.11M

+34.5%

EBITDA

$3.16M

+42.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$4.45M

-74.1%

Accounts Receivable

$97.33K

-96.3%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$10.68K

-33.8%

Return on Assets

-1.20%

N/A

Return on Invested Capital

-1.58%

N/A

Free Cash Flow

$2.62M

+46.0%

Operating Cash Flow

$2.61M

+46.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ECS.AXECS Botanics Holdings Ltd

ECS.AXECS Botanics Holdings Ltd$0.01+0.00%

HIQ.AXHITIQ Limited

HIQ.AXHITIQ Limited$0.01+0.00%

IVX.AXInvion Limited

IVX.AXInvion Limited$0.06-0.80%

VBS.AXVectus Biosystems Limited

VBS.AXVectus Biosystems Limited$0.11-8.33%

IXC.AXInvex Therapeutics Ltd

IXC.AXInvex Therapeutics Ltd$0.13+0.00%

BGT.AXBio-Gene Technology Limited

BGT.AXBio-Gene Technology Limited$0.04+0.00%

ICR.AXIntelicare Holdings Limited

ICR.AXIntelicare Holdings Limited$0.02-4.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About PER

What is the current price of Percheron Therapeutics Ltd?

Percheron Therapeutics Ltd is trading at A$0.01 per share.

What is the 52-week range for Percheron Therapeutics Ltd?

Over the past 52 weeks, Percheron Therapeutics Ltd has traded between A$0.00 and A$0.01.

How much debt does Percheron Therapeutics Ltd have?

As of the most recent reporting period, Percheron Therapeutics Ltd reported total debt of $25,865.

How much cash does Percheron Therapeutics Ltd have on hand?

Percheron Therapeutics Ltd reported $617,856 in cash and cash equivalents in its most recent financial results.

What is Percheron Therapeutics Ltd’s dividend yield?

Percheron Therapeutics Ltd does not currently have a dividend yield.

Percheron Therapeutics Ltd

Percheron Therapeutics Ltd Financials at a Glance

PER News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Percheron Therapeutics Ltd

PER Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Percheron Therapeutics Ltd Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PER

What is the current price of Percheron Therapeutics Ltd?

What is the 52-week range for Percheron Therapeutics Ltd?

How much debt does Percheron Therapeutics Ltd have?

How much cash does Percheron Therapeutics Ltd have on hand?

What is Percheron Therapeutics Ltd’s dividend yield?

Premium Investing Services